An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
Top results in this bookTable of Contents
Nursing Health Promotion [Internet].
Open Resources for Nursing (Open RN); Ernstmeyer K, Christman E Dr, editors.
Eau Claire (WI): Chippewa Valley Technical College; 2025.
Adverse Effects of Vaccines: Evidence and Causality.
Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors.
Washington (DC): National Academies Press (US); 2011 Aug 25.
Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling.
Mistry H, Naghdi S, Brown A, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Oct. (Health Technology Assessment, No. 28.63.)
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE, Scarborough M, Szubert A, et al.
Southampton (UK): NIHR Journals Library; 2018 Oct. (Health Technology Assessment, No. 22.59.)
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality.
Institute of Medicine (US) Vaccine Safety Committee; Stratton KR, Howe CJ, Johnston RB Jr, editors.
Washington (DC): National Academies Press (US); 1994.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Evidence review for symptoms and signs associated with bacterial meningitis: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review A1.
London: National Institute for Health and Care Excellence (NICE); 2024 Mar. (NICE Guideline, No. 240.)
Diseases of the Brain, Head and Neck, Spine 2024-2027: Diagnostic Imaging [Internet].
Hodler J, Kubik-Huch RA, Roos JE, editors.
Cham (CH): Springer; 2024.
Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2nd edition.
Geneva: World Health Organization; 2013.
Diseases of the Brain, Head and Neck, Spine 2020–2023: Diagnostic Imaging [Internet].
Hodler J, Kubik-Huch RA, von Schulthess GK, editors.
Cham (CH): Springer; 2020.
Selected Immune Disorders and Disability.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Selected Immune Disorders and Disability.
Washington (DC): National Academies Press (US); 2022 May 24.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Evidence review for corticosteroids in meningococcal disease: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management: Evidence review H.
An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
Shaw L, Bhattarai N, Cant R, et al.
Southampton (UK): NIHR Journals Library; 2020 May. (Health Technology Assessment, No. 24.24.)
Primary Care for Adults With HIV [Internet].
Dyer M, Kerr C, Vail RM, et al.
Baltimore (MD): Johns Hopkins University; 2025 Mar.
Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].
Gidengil C, Goetz MB, Maglione M, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. (Comparative Effectiveness Review, No. 244.)
Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition.
Walker HK, Hall WD, Hurst JW, editors.
Boston: Butterworths; 1990.
Ivosidenib (Tibsovo): Therapeutic area: Acute myeloid leukemia: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Jan.
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M, Archer R, Tosh J, et al.
Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Technology Assessment, No. 20.35.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on